PETIL: Predicting Expansion of Tumor Infiltrating Lymphocytes for the Adoptive Cell Immunotherapy in Bladder Cancers
Kayode D. Olumoyin, Ahmet Murat Aydın, Sarah Bazargan, Brittany L. Bunch, Ibrahim M. Chamseddine, Aleksandra M. Karolak, Matthew S. Beatty, Shari Pilon‐Thomas, Michael Adam Poch, Katarzyna Anna Rejniak
PETIL predicts TIL expansion in bladder cancer using demographic, clinical, and biological features, achieving AUC values of 0.740 and 0.857 in testing and validation cohorts.
bioRxiv · Oct 15, 2025 · PreprintImmunology